HomeSLNO • NASDAQ
add
Soleno Therapeutics Inc
Previous close
$48.38
Day range
$47.46 - $49.33
Year range
$41.50 - $90.32
Market cap
2.57B USD
Avg Volume
1.81M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 66.02M | — |
Operating expense | 42.16M | -46.86% |
Net income | 26.01M | 133.95% |
Net profit margin | 39.40 | — |
Earnings per share | — | — |
EBITDA | 23.22M | 129.46% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 498.93M | 94.31% |
Total assets | 599.90M | 102.18% |
Total liabilities | 105.09M | 228.33% |
Total equity | 494.80M | — |
Shares outstanding | 53.71M | — |
Price to book | 5.25 | — |
Return on assets | 12.19% | — |
Return on capital | 13.52% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 26.01M | 133.95% |
Cash from operations | 43.45M | 391.13% |
Cash from investing | -91.44M | -2,363.44% |
Cash from financing | 218.15M | 9,489.19% |
Net change in cash | 170.16M | 2,076.14% |
Free cash flow | 30.16M | 133.07% |
About
Founded
1999
Headquarters
Website
Employees
152
